The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. A previous guidance document …

Background Antimicrobial-resistant infections are commonly encountered in US hospitals
and result in significant morbidity and mortality. This guidance document provides …

Combination antibiotic therapy for invasive infections with Gram-negative bacteria is employed
in many health care facilities, especially for certain subgroups of patients, including those …

… Pranita D Tamma , Pranita D Tamma … D. serves as member of the advisory group for Qpex
Biopharma, Shionogi, and Merck; receives honoraria from Shionogi and Pfizer; receives other …

Importance Estimates of the incidence of overall antibiotic-associated adverse drug events (ADEs)
in hospitalized patients are generally unavailable. Objective To describe the …

Increasing antimicrobial resistance and medical device-related infections have led to a
renewed interest in phage therapy as an alternative or adjunct to conventional antimicrobials. …

Background The Infectious Diseases Society of America is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. This guidance document …

Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality …

Background. Carbapenem-resistant Enterobacteriaceae (CRE) are associated with considerable
mortality. As mechanisms of carbapenem resistance are heterogeneous, it is unclear if …

The Centers for Disease Control and Prevention Advisory Committee on Immunization
Practices recommends routine influenza vaccination for all women who are or will be pregnant …